GLP1 Analogues and the Risk of Osteoarthritis
NCT07360457 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 390
Last updated 2026-01-22
Summary
Assessing the effects of GLP1 RA Vs SGLT2 Inhibitors vs. Standard of care in joint pain, physical function, stiffness, and improving Quality of Life for patients with type 2 diabetes.
Conditions
Interventions
- DRUG
-
GLP-1 analog
glucagon like peptide analogues
- DRUG
-
SGLT2 inhibitor
sodium glucose transporter-2 inhibitors
- DRUG
-
Antidiabetic
Standard of care
Sponsors & Collaborators
-
Beni-Suef University
lead OTHER
Principal Investigators
-
Asmaa Elsayed · Sohag University
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-01
- Primary Completion
- 2026-12-01
- Completion
- 2027-03-01
More Related Trials
-
Insulin Glargine in Type 2 Diabetic Patients
NCT00347100 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
NCT01159353 ·Status: COMPLETED ·Phase: PHASE1
-
An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects
NCT02660502 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
NCT05048719 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Glulisine in Healthy Lean and Obese Subjects
NCT00311077 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Glulisine in Diabetes Mellitus, Type 2
NCT00174668 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus
NCT01689142 ·Status: COMPLETED ·Phase: PHASE3
-
Risk of Hypoglycemia in Type 2 Diabetes
NCT00734669 ·Status: COMPLETED
-
Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
NCT00859079 ·Status: COMPLETED ·Phase: PHASE4
-
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
NCT02911948 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
NCT00135096 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin Glulisine in Type 2 Diabetic Patients
NCT00360698 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes
NCT02132637 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
NCT01117350 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
NCT00135057 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
NCT07307235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants
NCT02955953 ·Status: COMPLETED ·Phase: PHASE1
-
Linagliptin Inpatient Trial
NCT02004366 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes
NCT06913881 ·Status: COMPLETED
-
Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)
NCT01212913 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects
NCT01967589 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
NCT01319240 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
NCT02749890 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
NCT02152371 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
NCT01122979 ·Status: COMPLETED ·Phase: PHASE4